Introduction Only symptomatic treatments are available for patients with Parkinson’s disease (PD), the second most common chronic neurodegenerative disease worldwide, and it is therefore imperative to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback